Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,988,200 | 3,109,322 | 2,650,134 | 1,665,412 | 1,231,707 |
| Marketable Securities | 670,700 | 698,972 | 518,108 | 423,254 | 250,612 |
| Receivables | 885,400 | 633,518 | 409,688 | 281,343 | 200,364 |
| Inventories | 280,800 | 167,502 | 124,360 | 111,830 | 77,604 |
| TOTAL | $8,133,400 | $4,822,829 | $3,843,109 | $2,648,963 | $1,831,540 |
| Non-Current Assets | |||||
| PPE Net | 958,500 | 745,080 | 812,005 | 789,437 | 698,362 |
| Intangibles | 1,402,200 | 1,402,158 | 50,384 | 79,384 | 334,724 |
| Other Non-Current Assets | 1,257,700 | 1,348,398 | 1,540,400 | 28,230 | 32,161 |
| TOTAL | $3,618,400 | $3,495,636 | $2,402,789 | $897,051 | $1,065,247 |
| Total Assets | $11,751,800 | $8,318,465 | $6,245,898 | $3,546,014 | $2,896,787 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 300,000 |
| Accounts payable and accrued liabilities | 155,100 | 87,610 | 110,987 | 73,994 | 61,451 |
| Accrued Expenses | 1,405,000 | 1,116,912 | 958,899 | 443,961 | 321,296 |
| Other current liabilities | 317,400 | 130,305 | 50,406 | 266,774 | 84,359 |
| TOTAL | $1,877,500 | $1,334,827 | $1,120,292 | $807,260 | $792,537 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | N/A | 6,005 |
| Other Non-Current Liabilities | 648,500 | 359,818 | 118,646 | 278,054 | 76,008 |
| TOTAL | $1,187,500 | $898,394 | $690,403 | $696,448 | $766,059 |
| Total Liabilities | $3,065,000 | $2,233,221 | $1,810,695 | $1,503,708 | $1,558,596 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 259,960 | 259,269 | 255,657 | 253,892 | 248,438 |
| Common Shares | 2,600 | 2,589 | 2,546 | 2,512 | 2,450 |
| Retained earnings | 858,700 | -1,852,978 | -2,989,478 | -5,119,723 | -5,373,836 |
| Other shareholders' equity | -68,500 | -1,973 | 659 | 2,155 | 202,782 |
| TOTAL | $8,686,800 | $6,085,244 | $4,435,203 | $2,042,306 | $1,338,191 |
| Total Liabilities And Equity | $11,751,800 | $8,318,465 | $6,245,898 | $3,546,014 | $2,896,787 |